Completed PHASE4 INTERVENTIONAL 1-arm NCT01529788

Onabotulinum Toxin Type A and Abobotulinum Toxin Type A Crow's Feet Rhytid Study

A Double Blinded Randomized Controlled Trial to Compare the Efficacy, Time to Onset, and Duration of Two Botulinum Type A Exotoxins (Onabotulinum Toxin A and Abobotulinum Toxin A) in the Treatment of Crow's Feet.

Sponsor: Medicis Pharmaceutical Corporation

Conditions Intrinsic Aging of Skin Solar Elastosis

Interventions Left lateral orbital injection of Botox Cosmetic or Dysport Right lateral orbital injection of Botox Cosmetic or Dysport

Updated 5 times since 2017 Last updated: Sep 29, 2014 Started: Sep 30, 2009 Primary completion: Sep 30, 2012 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Intrinsic Aging of Skin and Solar Elastosis, this trial is completed. The trial is conducted by Medicis Pharmaceutical Corporation and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medicis Pharmaceutical Corporation
The Maas Clinic

Data source: The Maas Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States